Reporting Bias in Diagnostic and Prognostic Studies: Time for Action (Editorial)
Clinical Chemistry, 2008, July, 54, 7
-
- €2.99
-
- €2.99
Publisher Description
Truth is not only violated by falsehood; it may be equally outraged by silence. --Henri-Frederic Amiel (1812-1881)
GENRE
Science & Nature
RELEASED
2008
1 July
LANGUAGE
EN
English
LENGTH
9
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
165.8
KB
Analytical Performance Characteristics should be Judged Against Objective Quality Specifications (Editorial)
1999
Fostering Integrity in Research
2017
Piercing the Veil of Corporate Secrecy About Clinical Trials (Essay)
2004
Proposals to Enhance the Quality of Observational Cohort Studies (Review)
2003
Doing Global Science
2016
Panel Discussion: How to Monitor and Minimize Variation and Mistakes (Clinical Chemistry Forum) (Discussion)
1997
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003